Trials / Completed
CompletedNCT04413110
PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 161 (actual)
- Sponsor
- Mansoura University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Transformed migraine is the most common and challenging subtype of chronic daily headache disorders35. Patients with transformed migraine often report an evolutionary process that occurs over months or years in which headaches increase in frequency, change characteristics and ultimately result in patterns of daily or near-daily headaches resembling a mixture of tension-type headache and migraine.
Detailed description
The present study aimed to investigate the presence and frequency of cognitive affection in patients with transformed migraines, as well as to analyze the association of cognitive affection with clinical features and headache impact, anxiety, depression, and quality of sleep.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Polysomnography | PSG was carried out for 41 patients with subjective cognitive impairment and 41 age and sex-matched controls. PSG with standard EEG montage that includes bilateral EOG and four EEG leads were used. A single attended overnight PSG study was performed at the Clinical Neurophysiology Unit of Mansoura University Hospitals. Patients were studied in a quiet, darkened room with no medications were used to induce sleep. All participants underwent one night of laboratory-based PSG. |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-03-01
- Completion
- 2020-04-01
- First posted
- 2020-06-02
- Last updated
- 2020-06-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04413110. Inclusion in this directory is not an endorsement.